Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Gains from Investment Securities (2019 - 2025)

IDEAYA Biosciences (IDYA) has disclosed Gains from Investment Securities for 7 consecutive years, with $1.6 million as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities rose 247.07% to $1.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$45000.0 through Dec 2025, up 93.96% year-over-year, with the annual reading at $481757.0 for FY2025, 93.77% down from the prior year.
  • Gains from Investment Securities hit $1.6 million in Q4 2025 for IDEAYA Biosciences, down from $11.3 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $11.3 million in Q3 2025 to a low of -$2.7 million in Q4 2023.
  • Historically, Gains from Investment Securities has averaged $2.5 million across 5 years, with a median of $971268.5 in 2021.
  • Biggest five-year swings in Gains from Investment Securities: surged 15100.0% in 2021 and later plummeted 551.0% in 2023.
  • Year by year, Gains from Investment Securities stood at -$4000.0 in 2021, then soared by 15100.0% to $600000.0 in 2022, then tumbled by 551.0% to -$2.7 million in 2023, then soared by 117.04% to $461000.0 in 2024, then soared by 247.07% to $1.6 million in 2025.
  • Business Quant data shows Gains from Investment Securities for IDYA at $1.6 million in Q4 2025, $11.3 million in Q3 2025, and $178812.0 in Q2 2025.